ADHD Flashcards
What does ADHD stand for?
- Attention Deficit
- Hyperactivity
- Disorder
What is ADHD?
A co-occurring cluster of impairing symptoms, relating to self-regulation (‘executive functioning’).
ADHD is a diagnostic triad of….
- Inattention.
- Hyperactivity.
- Impulsivity.
What is ‘combined type’ ADHD also known as?
Hyperkinetic disorder.
For a diagnosis of ‘combined type’ ADHD to be made, what criteria must be met?
Triad of difficulties, which are:
- developmentally inappropriate.
- impairing.
- pervasive.
- longstanding.
How may the core symptoms of ADHD impact someone at home and in the community?
- Complicated to parent.
- Raised family stress levels.
- Increased anger and upset.
- Increased risk of harm (ie. impulsive behaviour).
How may the core symptoms of ADHD impact on school life?
- Barrier to learning.
- Frequently in trouble.
- Disorganisation, forgetting, losing things.
Give examples of co-morbid difficulties with ADHD.
- Social communication difficulties.
- LD.
- Attachment difficulties.
- Mood and anxiety problems.
- Behavioural disorders (ODD/CD (ADHD is almost always present in conduct disorder)).
- Substance use.
Outline the psychological management in ADHD.
1st line - parent training
2nd line - social skills training (sleep + diet)
Outline the pharmacological management in ADHD.
1st line - Methylphenidate (ritalin - a stimulant)
2nd line - Atomoxetine
3rd line - antidepressants, antipsychotics
What are medications used in the treatment of ADHD known as?
Stimulants
What do stimulants do?
Improve dopaminergic neurotransmission in networks involved in executive functioning.
Particularly affect the prefrontal cortex, amongst many.
This directly improves the core symptoms as a result.
Describe the side effects of stimulants.
Side effects are usually minor, and involve appetite and sleep reduction
Dysphoria, anxiety and tics are also possible
Give 2 examples of non-stimulant drugs which can be used in the treatment of ADHD, and detail their mode of action.
Atomoxetine – noradrenergic and dopaminergic agonist.
Guanfacine – alpha-2 agonist, effects on prefrontal cortex/ADHD control.